ORBi: Hiligsmann Mickaël - Cost-effectiveness of denosumab compared with oral bisphosphonates in the treatment of postmenopausal osteoporotic women

Reference : Cost-effectiveness of denosumab compared with oral bisphosphonates in the treatment of p...


	Document type :	Scientific congresses and symposiums : Paper published in a journal
	Discipline(s) :	Business & economic sciences : Special economic topics (health, labor, transportation…) Human health sciences : Rheumatology
	To cite this reference:	http://hdl.handle.net/2268/60614

Title :	Cost-effectiveness of denosumab compared with oral bisphosphonates in the treatment of postmenopausal osteoporotic women
Language :	English
Author, co-author :	Hiligsmann, Mickaël [Université de Liège - ULg > HEC-Ecole de gestion de l'ULg : UER > Economie industrielle >]
	Reginster, Jean-Yves [Université de Liège - ULg > Département des sciences de la santé publique > Epidémiologie et santé publique >]
Publication date :	May-2010
Journal title :	Osteoporosis International
Publisher :	Springer Science & Business Media B.V.
Volume :	21
Issue/season :	S1
Pages :	30
Audience :	International
ISSN :	0937-941X
e-ISSN :	1433-2965
City :	Godalming
Country :	United Kingdom
Event name :	IOF World Congress on Osteoporosis & 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthrithis
Event date :	du 5 mai 2010 au 8 mai 2010
Event organizer :	European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis
Event place (city) :	Florence
Event country :	Italie
Target :	Researchers ; Professionals
Permalink :	http://hdl.handle.net/2268/60614

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	Abstract1_IOF2010.pdf		Author preprint	62.38 kB	Request copy

Additional material(s):

	File	Commentary	Version	Size	Access
Restricted access	Oral_IOF2O10.ppt	Communication orale	-	155.5 kB	Request copy

All documents in ORBi are protected by a user license.